お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
982363

有効性試験の世界市場:試験タイプ別、アプリケーション別の予測(2025年まで)およびCOVID-19の累積的影響

Efficacy Testing Market Research Report by Test Type, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=108.90円
有効性試験の世界市場:試験タイプ別、アプリケーション別の予測(2025年まで)およびCOVID-19の累積的影響
出版日: 2021年02月04日
発行: 360iResearch LLP
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の有効性試験の市場規模は、2020年の2億5,391万米ドルから、2025年末までに3億3,644万米ドルに拡大すると予想されています。

当レポートは、世界の有効性試験市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の影響、試験タイプ別・アプリケーション・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制約事項
  • 利害関係者

第2章 調査方法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データ解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画の作成
    • 実行:調査の実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • テストタイプ別市場の見通し
  • アプリケーション別市場の見通し
  • 地域別市場の見通し
  • 競合他社の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響
  • 地理的な成長機会

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 試験タイプ別市場

  • イントロダクション
  • 抗菌/防腐効果試験
    • 迅速検査法
    • 従来の試験方法
  • 消毒剤の有効性テスト
    • 表面試験方法
    • サスペンション試験方法

第7章 アプリケーション別市場

  • イントロダクション
  • 消費財
  • 化粧品およびパーソナルケア製品
  • 医療機器
  • 医薬品製造

第8章 南北アメリカ市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第10章 欧州、中東・アフリカ市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第12章 企業プロファイル

  • 3M Group
  • Abbott Analytical
  • Accugen Laboratories, Inc.
  • Betco
  • Bioscience Laboratories, Inc.
  • Blutest Laboratories Limited
  • Cantel Medical Corporation
  • Charles River Laboratories International, Inc.
  • Diversey, Inc.
  • Ecolab Inc.
  • Eurofins Scientific
  • Intertek Group PLC
  • Medline Industries, Inc.
  • Pacific Biolabs
  • Reckitt Benckiser Group PLC
  • SGS SA
  • Steris PLC
  • The Clorox Company
  • The Procter & Gamble Company
  • WuXi AppTec

第13章 付録

  • 考察ガイド
図表

List of Figures

  • FIGURE 1. GLOBAL EFFICACY TESTING MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL EFFICACY TESTING MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL EFFICACY TESTING MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL EFFICACY TESTING MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 9. GLOBAL EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 11. GLOBAL EFFICACY TESTING MARKET: MARKET DYNAMICS
  • FIGURE 12. GLOBAL EFFICACY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 13. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (%)
  • FIGURE 14. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2025
  • FIGURE 16. GLOBAL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL EFFICACY TESTING MARKET SIZE, BY RAPID TEST METHOD, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL EFFICACY TESTING MARKET SIZE, BY TRADITIONAL TEST METHOD, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL EFFICACY TESTING MARKET SIZE, BY SURFACE TEST METHOD, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL EFFICACY TESTING MARKET SIZE, BY SUSPENSION TEST METHOD, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
  • FIGURE 23. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2025
  • FIGURE 25. GLOBAL EFFICACY TESTING MARKET SIZE, BY CONSUMER PRODUCT APPLICATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL EFFICACY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCT APPLICATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL EFFICACY TESTING MARKET SIZE, BY MEDICAL DEVICE APPLICATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL EFFICACY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING APPLICATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. AMERICAS EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 30. AMERICAS EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 32. ARGENTINA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. BRAZIL EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. CANADA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. MEXICO EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. UNITED STATES EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 38. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 40. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. CHINA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. INDIA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. INDONESIA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. JAPAN EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. MALAYSIA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. THAILAND EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 52. FRANCE EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. GERMANY EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. ITALY EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. QATAR EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. RUSSIA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. SPAIN EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. GLOBAL EFFICACY TESTING MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL EFFICACY TESTING MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 65. GLOBAL EFFICACY TESTING MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL EFFICACY TESTING MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL EFFICACY TESTING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL EFFICACY TESTING MARKET SIZE, BY RAPID TEST METHOD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL EFFICACY TESTING MARKET SIZE, BY TRADITIONAL TEST METHOD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL EFFICACY TESTING MARKET SIZE, BY SURFACE TEST METHOD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL EFFICACY TESTING MARKET SIZE, BY SUSPENSION TEST METHOD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL EFFICACY TESTING MARKET SIZE, BY CONSUMER PRODUCT APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL EFFICACY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCT APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL EFFICACY TESTING MARKET SIZE, BY MEDICAL DEVICE APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL EFFICACY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. BRAZIL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CANADA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. MEXICO EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. UNITED STATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. UNITED STATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CHINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CHINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. INDIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. INDIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. INDONESIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. INDONESIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. JAPAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. JAPAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. MALAYSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. MALAYSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. THAILAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. THAILAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. FRANCE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. FRANCE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. GERMANY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. GERMANY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ITALY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ITALY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. QATAR EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. QATAR EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. RUSSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. RUSSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. SPAIN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. SPAIN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. GLOBAL EFFICACY TESTING MARKET: SCORES
  • TABLE 76. GLOBAL EFFICACY TESTING MARKET: BUSINESS STRATEGY
  • TABLE 77. GLOBAL EFFICACY TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 78. GLOBAL EFFICACY TESTING MARKET: RANKING
  • TABLE 79. GLOBAL EFFICACY TESTING MARKET: MERGER & ACQUISITION
  • TABLE 80. GLOBAL EFFICACY TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 81. GLOBAL EFFICACY TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 82. GLOBAL EFFICACY TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 83. GLOBAL EFFICACY TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 84. GLOBAL EFFICACY TESTING MARKET: LICENSE & PRICING
目次
Product Code: MRR-62635CB

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Efficacy Testing Market is expected to grow from USD 253.91 Million in 2020 to USD 336.44 Million by the end of 2025.

2. The Global Efficacy Testing Market is expected to grow from EUR 222.63 Million in 2020 to EUR 295.00 Million by the end of 2025.

3. The Global Efficacy Testing Market is expected to grow from GBP 197.92 Million in 2020 to GBP 262.25 Million by the end of 2025.

4. The Global Efficacy Testing Market is expected to grow from JPY 27,099.41 Million in 2020 to JPY 35,907.26 Million by the end of 2025.

5. The Global Efficacy Testing Market is expected to grow from AUD 368.72 Million in 2020 to AUD 488.56 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Efficacy Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Test Type, the Efficacy Testing Market studied across Antimicrobial/Preservative Efficacy Testing and Disinfectant Efficacy Testing. The Antimicrobial/Preservative Efficacy Testing further studied across Rapid Test Method and Traditional Test Method. The Disinfectant Efficacy Testing further studied across Surface Test Method and Suspension Test Method.

Based on Application, the Efficacy Testing Market studied across Consumer Product Applications, Cosmetics & Personal Care Product Applications, Medical Device Applications, and Pharmaceutical Manufacturing Applications.

Based on Geography, the Efficacy Testing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Efficacy Testing Market including 3M Group, Abbott Analytical, Accugen Laboratories, Inc., Betco, Bioscience Laboratories, Inc., Blutest Laboratories Limited, Cantel Medical Corporation, Charles River Laboratories International, Inc., Diversey, Inc., Ecolab Inc., Eurofins Scientific, Intertek Group PLC, Medline Industries, Inc., Pacific Biolabs, Reckitt Benckiser Group PLC, SGS SA, Steris PLC, The Clorox Company, The Procter & Gamble Company, and WuXi AppTec.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Efficacy Testing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Efficacy Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Efficacy Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Efficacy Testing Market?

4. What is the competitive strategic window for opportunities in the Global Efficacy Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Efficacy Testing Market?

6. What are the modes and strategic moves considered suitable for entering the Global Efficacy Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Test Type Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High focus on contamination control in products
      • 5.1.1.2. Increasing investments for the research and development activities in the pharmaceutical sector
      • 5.1.1.3. Growing applications of antimicrobial efficacy testing in various medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in different efficacy testing and trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Government policies and efforts towards new product safety and stability mainly in the pharma and medical sector
      • 5.1.3.2. Emerging economies providing rapid growth in end-use industries
    • 5.1.4. Challenges
      • 5.1.4.1. Complex and time-consuming process
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Efficacy Testing Market, By Test Type

  • 6.1. Introduction
  • 6.2. Antimicrobial/Preservative Efficacy Testing
    • 6.2.1. Rapid Test Method
    • 6.2.2. Traditional Test Method
  • 6.3. Disinfectant Efficacy Testing
    • 6.3.1. Surface Test Method
    • 6.3.2. Suspension Test Method

7. Global Efficacy Testing Market, By Application

  • 7.1. Introduction
  • 7.2. Consumer Product Applications
  • 7.3. Cosmetics & Personal Care Product Applications
  • 7.4. Medical Device Applications
  • 7.5. Pharmaceutical Manufacturing Applications

8. Americas Efficacy Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Efficacy Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Efficacy Testing Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. 3M Group
  • 12.2. Abbott Analytical
  • 12.3. Accugen Laboratories, Inc.
  • 12.4. Betco
  • 12.5. Bioscience Laboratories, Inc.
  • 12.6. Blutest Laboratories Limited
  • 12.7. Cantel Medical Corporation
  • 12.8. Charles River Laboratories International, Inc.
  • 12.9. Diversey, Inc.
  • 12.10. Ecolab Inc.
  • 12.11. Eurofins Scientific
  • 12.12. Intertek Group PLC
  • 12.13. Medline Industries, Inc.
  • 12.14. Pacific Biolabs
  • 12.15. Reckitt Benckiser Group PLC
  • 12.16. SGS SA
  • 12.17. Steris PLC
  • 12.18. The Clorox Company
  • 12.19. The Procter & Gamble Company
  • 12.20. WuXi AppTec

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.